Chronic lymphocytic leukemia (CLL) diagnosis relies heavily on laboratory analyses of blood samples. These analyses provide crucial information about the quantity and characteristics of white blood cells, specifically lymphocytes. A complete blood count (CBC) often reveals an elevated lymphocyte count, a key indicator of CLL. Further tests, such as flow cytometry and immunophenotyping, analyze cell surface markers to confirm the diagnosis and classify the specific type of CLL. Genetic testing may also be performed on the blood sample to identify specific chromosomal abnormalities associated with the disease and aid in prognosis.
Accurate and timely hematological evaluation plays a vital role in CLL management. These evaluations help clinicians determine the stage of the disease, predict its course, and monitor treatment effectiveness. The development and refinement of these laboratory techniques have significantly improved the understanding and management of CLL over time, allowing for earlier diagnosis and more personalized treatment strategies.